Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Cartesian Therapeutics, Inc. | 94,226 | reported | 02 Jan 2026 | tx 16+196,150−39,447 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Jan 2026 | GRANT_AWARD | Cartesian Therapeutics, Inc. | 24,000 | 0.00 USD | |
| 02 Jan 2026 | GRANT_AWARD | Cartesian Therapeutics, Inc. | 71,000 | 0.00 USD | deriv |
| 30 Dec 2025 | EXERCISE | Cartesian Therapeutics, Inc. | 7,500 | 3.30 USD | |
| 30 Dec 2025 | EXERCISE | Cartesian Therapeutics, Inc. | 7,500 | — | deriv |
| 28 Nov 2025 | EXERCISE | Cartesian Therapeutics, Inc. | 7,500 | 3.30 USD | |
| 28 Nov 2025 | EXERCISE | Cartesian Therapeutics, Inc. | 7,500 | — | deriv |
| 12 May 2025 | EXERCISE | Cartesian Therapeutics, Inc. | 7,500 | 3.30 USD | |
| 12 May 2025 | EXERCISE | Cartesian Therapeutics, Inc. | 7,500 | — | deriv |
| 15 Apr 2025 | EXERCISE | Cartesian Therapeutics, Inc. | 7,500 | 3.30 USD | |
| 15 Apr 2025 | EXERCISE | Cartesian Therapeutics, Inc. | 7,500 | — | deriv |
| 06 Jan 2025 | SALE | Cartesian Therapeutics, Inc. | 906 | 16.83 USD | |
| 03 Jan 2025 | SALE | Cartesian Therapeutics, Inc. | 891 | 16.72 USD | |
| 02 Jan 2025 | GRANT_AWARD | Cartesian Therapeutics, Inc. | 16,100 | 0.00 USD | |
| 02 Jan 2025 | GRANT_AWARD | Cartesian Therapeutics, Inc. | 47,400 | 0.00 USD | deriv |
| 26 Dec 2024 | EXERCISE | Cartesian Therapeutics, Inc. | 7,650 | 3.30 USD | |
| 26 Dec 2024 | EXERCISE | Cartesian Therapeutics, Inc. | 7,650 | — | deriv |